Trial Profile
Identification of a specific systemic transcriptome able to differentiate patients with renal transplantation in chronic treatment with tacrolimus from those with mTOR inhibitors.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Everolimus; Sirolimus
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- 18 Mar 2015 New trial record